316 related articles for article (PubMed ID: 28184152)
1. Drug delivery in overcoming the blood-brain barrier: role of nasal mucosal grafting.
Marianecci C; Rinaldi F; Hanieh PN; Di Marzio L; Paolino D; Carafa M
Drug Des Devel Ther; 2017; 11():325-335. PubMed ID: 28184152
[TBL] [Abstract][Full Text] [Related]
2. Permeabilization of the blood-brain barrier via mucosal engrafting: implications for drug delivery to the brain.
Bleier BS; Kohman RE; Feldman RE; Ramanlal S; Han X
PLoS One; 2013; 8(4):e61694. PubMed ID: 23637885
[TBL] [Abstract][Full Text] [Related]
3. From nose to brain: understanding transport capacity and transport rate of drugs.
Wu H; Hu K; Jiang X
Expert Opin Drug Deliv; 2008 Oct; 5(10):1159-68. PubMed ID: 18817519
[TBL] [Abstract][Full Text] [Related]
4. Direct CNS delivery of proteins using thermosensitive liposome-in-gel carrier by heterotopic mucosal engrafting.
Pawar GN; Parayath NN; Nocera AL; Bleier BS; Amiji MM
PLoS One; 2018; 13(12):e0208122. PubMed ID: 30517163
[TBL] [Abstract][Full Text] [Related]
5. Intranasal Drug Delivery: A Non-Invasive Approach for the Better Delivery of Neurotherapeutics.
Kumar H; Mishra G; Sharma AK; Gothwal A; Kesharwani P; Gupta U
Pharm Nanotechnol; 2017; 5(3):203-214. PubMed ID: 28521670
[TBL] [Abstract][Full Text] [Related]
6. Nanosized Drug Delivery Systems for Direct Nose to Brain Targeting: A Review.
Phukan K; Nandy M; Sharma RB; Sharma HK
Recent Pat Drug Deliv Formul; 2016; 10(2):156-64. PubMed ID: 26996366
[TBL] [Abstract][Full Text] [Related]
7. Drug Delivery and Targeting to the Brain Through Nasal Route: Mechanisms, Applications and Challenges.
Kashyap K; Shukla R
Curr Drug Deliv; 2019; 16(10):887-901. PubMed ID: 31660815
[TBL] [Abstract][Full Text] [Related]
8. Recent patents review on intranasal administration for CNS drug delivery.
Jogani V; Jinturkar K; Vyas T; Misra A
Recent Pat Drug Deliv Formul; 2008; 2(1):25-40. PubMed ID: 19075895
[TBL] [Abstract][Full Text] [Related]
9. CNS drug delivery systems: novel approaches.
Pathan SA; Iqbal Z; Zaidi SM; Talegaonkar S; Vohra D; Jain GK; Azeem A; Jain N; Lalani JR; Khar RK; Ahmad FJ
Recent Pat Drug Deliv Formul; 2009 Jan; 3(1):71-89. PubMed ID: 19149731
[TBL] [Abstract][Full Text] [Related]
10. Nanoneurotherapeutics approach intended for direct nose to brain delivery.
Md S; Mustafa G; Baboota S; Ali J
Drug Dev Ind Pharm; 2015; 41(12):1922-34. PubMed ID: 26057769
[TBL] [Abstract][Full Text] [Related]
11. Direct nose to brain drug delivery via integrated nerve pathways bypassing the blood-brain barrier: an excellent platform for brain targeting.
Pardeshi CV; Belgamwar VS
Expert Opin Drug Deliv; 2013 Jul; 10(7):957-72. PubMed ID: 23586809
[TBL] [Abstract][Full Text] [Related]
12. The blood-brain barrier and nasal drug delivery to the central nervous system.
Miyake MM; Bleier BS
Am J Rhinol Allergy; 2015; 29(2):124-7. PubMed ID: 25785753
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in blood-brain barrier disruption as a CNS delivery strategy.
Bellavance MA; Blanchette M; Fortin D
AAPS J; 2008; 10(1):166-77. PubMed ID: 18446517
[TBL] [Abstract][Full Text] [Related]
14. In-vitro blood-brain barrier models for drug screening and permeation studies: an overview.
Bagchi S; Chhibber T; Lahooti B; Verma A; Borse V; Jayant RD
Drug Des Devel Ther; 2019; 13():3591-3605. PubMed ID: 31695329
[TBL] [Abstract][Full Text] [Related]
15. Noninvasive and targeted drug delivery to the brain using focused ultrasound.
Burgess A; Hynynen K
ACS Chem Neurosci; 2013 Apr; 4(4):519-26. PubMed ID: 23379618
[TBL] [Abstract][Full Text] [Related]
16. Transporters at CNS barrier sites: obstacles or opportunities for drug delivery?
Sanchez-Covarrubias L; Slosky LM; Thompson BJ; Davis TP; Ronaldson PT
Curr Pharm Des; 2014; 20(10):1422-49. PubMed ID: 23789948
[TBL] [Abstract][Full Text] [Related]
17. Targeted drug delivery to central nervous system (CNS) for the treatment of neurodegenerative disorders: trends and advances.
Goyal K; Koul V; Singh Y; Anand A
Cent Nerv Syst Agents Med Chem; 2014; 14(1):43-59. PubMed ID: 25360772
[TBL] [Abstract][Full Text] [Related]
18. Nano carriers for drug transport across the blood-brain barrier.
Li X; Tsibouklis J; Weng T; Zhang B; Yin G; Feng G; Cui Y; Savina IN; Mikhalovska LI; Sandeman SR; Howel CA; Mikhalovsky SV
J Drug Target; 2017 Jan; 25(1):17-28. PubMed ID: 27126681
[TBL] [Abstract][Full Text] [Related]
19. Nasal Drug Delivery of Anticancer Drugs for the Treatment of Glioblastoma: Preclinical and Clinical Trials.
Bruinsmann FA; Richter Vaz G; de Cristo Soares Alves A; Aguirre T; Raffin Pohlmann A; Stanisçuaski Guterres S; Sonvico F
Molecules; 2019 Nov; 24(23):. PubMed ID: 31779126
[TBL] [Abstract][Full Text] [Related]
20. Drug delivery to the brain in Alzheimer's disease: consideration of the blood-brain barrier.
Banks WA
Adv Drug Deliv Rev; 2012 May; 64(7):629-39. PubMed ID: 22202501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
